secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2022-10-19T23:59:59+00:00
Accession:  0001193125-22-264838
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health Q3 GAAP EPS $6.68, adj. $7.53; revenue up 11.5%; raises FY2022 outlook
--------------------------------------------------------------------------------

- GAAP net income $6.68/share vs $6.79 adjusted; adjusted EPS $7.53, up 10.9% YoY.
- Operating revenue $39.6B (+11.5% YoY), driven by membership growth and premium rate increases.
- Medical membership 47.3M, up 2.2M YoY (+4.9%), with growth in Medicaid, commercial fee-based, and Medicare Advantage.
- FY2022 GAAP net income guidance raised to >$25.33/share; adjusted net income >$28.95/share.
- Q4 dividend declared $1.28/share, payable Dec 21, 2022 to holders of record Dec 5.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000119312522264838/0001193125-22-264838-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000119312522264838/d401070d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-264838

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer